News
ANGO
12.78
-0.12%
-0.02
Here are the major earnings before the open Tuesday
Seeking Alpha · 5h ago
AngioDynamics Q4 2026 Earnings Preview
Seeking Alpha · 5h ago
Weekly Report: what happened at ANGO last week (0706-0710)?
Weekly Report · 18h ago
Weekly Report: what happened at ANGO last week (0629-0703)?
Weekly Report · 07/06 09:07
AngioDynamics to report fiscal 2026 fourth-quarter and full-year results, host conference call
PUBT · 06/30 12:00
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
Barchart · 06/30 07:00
Weekly Report: what happened at ANGO last week (0622-0626)?
Weekly Report · 06/29 09:07
Weekly Report: what happened at ANGO last week (0615-0619)?
Weekly Report · 06/22 09:08
FDA Approves AngioDynamics' IDE For RELIEF Study Testing NanoKnife In Benign Prostate Hyperplasia
NASDAQ · 06/18 09:22
AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia
Benzinga · 06/17 12:37
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
TipRanks · 06/17 12:35
AngioDynamics wins FDA IDE approval for RELIEF feasibility study of NanoKnife in BPH
PUBT · 06/17 12:31
ANGIODYNAMICS RECEIVES FDA IDE APPROVAL FOR RELIEF FEASIBILITY STUDY EVALUATING NANOKNIFE IRE PLATFORM AS MINIMALLY INVASIVE TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
Reuters · 06/17 12:30
Weekly Report: what happened at ANGO last week (0608-0612)?
Weekly Report · 06/15 09:07
AngioDynamics Targets BPH Market With New NanoKnife Trial: What Investors Should Watch
TipRanks · 06/11 16:32
AngioDynamics lifts FY2026 net sales outlook to $313.5-$315.5 million
PUBT · 06/10 13:43
Weekly Report: what happened at ANGO last week (0601-0605)?
Weekly Report · 06/08 09:07
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
Benzinga · 06/03 12:29
Weekly Report: what happened at ANGO last week (0525-0529)?
Weekly Report · 06/01 09:08
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)
TipRanks · 05/29 13:31
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.